Cerus's average Accounts Receivable for the
three
months ended in Dec. 2023 was $30.0 Mil. Cerus's Revenue for the
three
months ended in Dec. 2023 was $46.8 Mil.
Hence, Cerus's Days Sales Outstanding for the
three
months ended in Dec. 2023 was 58.58.
The historical rank and industry rank for Cerus's Days Sales Outstanding or its related term are showing as below:
CERS'
s Days Sales Outstanding Range Over the Past 10 Years
Min: 58.22 Med: 63.99 Max: 81.61
Current: 66.24
During the past 13 years, Cerus's highest Days Sales Outstanding was 81.61. The lowest was 58.22. And the median was 63.99.
CERS's Days Sales Outstanding is ranked worse than 52.66% of 807
companies
in the Medical Devices & Instruments industry
Industry Median: 63.94
vs CERS: 66.24
Cerus's Days Sales Outstanding
declined
from Dec. 2022 (64.84) to Dec. 2023 (58.58).
Cerus Days Sales Outstanding Historical Data
The historical data trend for Cerus's Days Sales Outstanding can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Cerus's Days Sales Outstanding
For the Medical Devices subindustry, Cerus's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Cerus's Days Sales Outstanding Distribution in the Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Cerus's Days Sales Outstanding distribution charts can be found below:
* The bar in red indicates where Cerus's Days Sales Outstanding falls into.
Cerus Days Sales Outstanding Calculation
Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Cerus (NAS:CERS) Days Sales Outstanding Explanation
For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.
Cerus Days Sales Outstanding Related Terms
Thank you for viewing the detailed overview of Cerus's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.
Cerus Corp is a biomedical products company focused on the field of blood transfusion safety. The INTERCEPT Blood System is designed to reduce the risk of transfusion-transmitted infections by inactivating a broad range of pathogens such as viruses, bacteria, and parasites. The company sells its INTERCEPT platelet and plasma systems in the United States of America, Europe, the Commonwealth of Independent States countries, the Middle East, and selected countries in other regions around the world. The firm continues to operate in only one segment: Blood safety and generates revenue from the same.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
CERS has been successfully added to your 